Key result
Polyclonal sera from animals immunized with individual enteroviruses demonstrated both binding and neutralization activities against heterologous enteroviruses.
Why the study?
Although enterovirus infection leads to cross-reactive antibodies, their clinical relevance is unclear given an estimated incidence of enterovirus infections of one per year.
Cross-reactive antibodies generated against individual enteroviruses can bind and neutralize heterologous enteroviruses, potentially modulating infection and disease severity.
Enteroviruses (EVs) are common human pathogens. Although infection with EVs leads to cross-reactive antibodies, the clinical relevance of these antibodies is unclear given the estimated incidence of EV infections in the general population of one per year. The hypothesis that anti-EV cross-reactive antibodies can bind and neutralize heterologous EVs was investigated using polyclonal sera collected from animals immunized with individual EVs. Both binding and neutralization activities against heterologous EVs was observed in these sera, and we speculate that cross-reactive antibodies may modulate infection and disease severity. Defining the antigenic relationship among EVs may provide insights into the epidemiology and pathogenesis of enterovirus infections.
No takes yet. Share an insight, caveat, or question.
Rosenfeld et al. (2022) studied Enterovirus infections. Immunization with individual enteroviruses was evaluated on Binding and neutralization activities against heterologous enteroviruses. Polyclonal sera from animals immunized with individual enteroviruses demonstrated both binding and neutralization activities against heterologous enteroviruses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: